№ lp_1_08626
Shared care protocol defining clinical responsibilities, prescribing arrangements, monitoring requirements, and administration guidance for riluzole in adult patients with amyotrophic lateral sclerosis within NHS services.
Year: 2026
Version: NENC v2.0
Date published: 22 January 2026
Planned review date: October 2027
Region: North East and North Cumbria
Healthcare system: NHS
Clinical area: Neurology
Condition: Amyotrophic lateral sclerosis
Medicine: Riluzole
Document type: Shared care protocol
Indication: Extension of survival or time to mechanical ventilation in ALS
Target population: Adults
Intended audience: NHS healthcare professionals
Initiating authority: Neurological specialist services
Regulatory reference: NICE Technology Appraisal TA20
Prescribing setting: Secondary to primary care transfer
Monitoring requirements: Liver function tests, full blood count, urea and electrolytes
Route of administration: Oral or enteral
Licensing status: Licensed for ALS only
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.